3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
11
Phase 2
4
Phase 1/2
3
Phase NA
2
Phase EARLY_PHASE1
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Pancreatic Neoplasms
3
Glioblastoma
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Squamous Cell Carcinoma of Head and Neck
1
Oligodendroglioma
1
Glioma
1
Childhood Brain Neoplasm
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Astrocytoma
1
Acidemia, isovaleric
1
Interventions
poly ICLC
2
Radiotherapy
2
Biopsy
2
lorlatinib
1
fluorodopa F 18
1
fimepinostat
1
Temozolomide
1
Surgical Procedures, Operative
1
Standard of Care
1
Radiation
1
Protein Subunit Vaccines
1
Practice Guidelines as Topic
1
Perfusion Magnetic Resonance Imaging
1
Magnetic Resonance Spectroscopy
1
Ketoconazole
1
Gadolinium DTPA
1
Fingolimod Hydrochloride
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Donepezil
1
Diffusion Magnetic Resonance Imaging
1
CUDC-907
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Astrocytoma
×
Surgical Procedures, Operative
×
Clear all
NCT05577416
2026-03-18
AB-218-IIT-201
Melbourne Health
Phase EARLY_PHASE1
Completed
14 enrolled